Start Here

The normal sequence

A listing, ad, registry page, or referral is usually the first public layer. It rarely contains the full schedule, all restrictions, or all payment details. A coordinator may then do a phone pre-screen, send a secure form, or schedule an in-person screening visit.

Pre-screening usually checks broad rules: age range, sex, diagnosis, medication use, recent procedures, pregnancy status, smoking, body weight, recent study participation, availability, and distance from the site. Formal screening may include consent review, medical history, medication review, vitals, blood draw, urine test, ECG, pregnancy test, questionnaires, physical exam, or records review.

Enrollment usually happens only after screening results are reviewed. A person can pass the phone screen and still fail formal screening because of labs, ECG findings, medication conflicts, recent trial participation, scheduling windows, or a protocol rule the recruiter did not ask about at first.

What the consent form should clarify

The consent form should identify the sponsor, research site, principal investigator, purpose of the study, procedures, expected time commitment, foreseeable risks, possible benefits, alternatives, privacy protections, payment terms, injury-related contact instructions, and the process for leaving the study. Read the schedule of events carefully. That table often matters more than the summary because it shows when blood draws, procedures, questionnaires, dosing, diaries, or follow-up contacts occur.

Ask for time to read the consent form before signing. For a study with medication, device use, blood draws, overnight stays, imaging, biopsies, washout periods, or long follow-up, read the sections on risks, restrictions, and compensation more than once. Keep a copy of the signed consent form and any visit schedule you receive.

Slow down when the process gets vague

Slow down when a recruiter cannot name the study site, refuses to provide an NCT number, asks for payment, asks for ID or records before verification, pressures same-day signing, or avoids basic questions about visit burden and payment timing. A legitimate site should be able to explain the sponsor, investigator, location, schedule, screening process, payment structure, privacy process, and contact path in ordinary language.

How to decide whether to take the next step

Do not rely on the headline payment or the condition name. Decide from the schedule, the screening requirements, the procedures, the restrictions, and the payment timing. A useful first call should leave you with enough detail to answer these questions: Can I get to every required visit? Can I follow the restrictions without disrupting work, childcare, medication routines, or ordinary medical care? Do I understand how payment is earned? Do I know who is responsible if a symptom or abnormal result comes up?

If any of those answers are unclear, ask for clarification before scheduling. It is reasonable to say, “Before I set up screening, I need the visit schedule, screening payment, and the main eligibility rules that usually exclude people.” A research site that routinely screens participants should be able to answer that without making the call difficult.

When to involve your own clinician

Contact your own clinician before changing prescribed medication, stopping treatment, delaying care, joining a study that affects an active condition, or entering a study that requires washout from medication you use regularly. The research site evaluates eligibility for the study. Your own clinician understands your ongoing care, history, and risk tolerance. Bring the consent form or protocol summary to that discussion when the study involves medication changes, device use, procedures, imaging, pregnancy-related rules, or abnormal screening results.